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Strengths and limitations of this study
 ► The study attempts to address the key issues of 
sputum sample adequacy (in terms of its quality and 
quantity) submitted by presumptive pulmonary TB 
patients under the programmatic settings.
 ► The study would also assess the feasibility of using 
mobile phone video demonstrating sputum expec-
toration step- by- step with instructions in the local 
language under the programmatic settings.
 ► As a part of video validation, the study will also 
gain participants’ perspectives on the intervention 
through feedback.
 ► The non- randomised study design is a limitation.
 ► To limit the selection bias, we propose to select two 
pairs of designated microscopy centres (located at 
secondary and primary healthcare facilities) which 
are matched for sputum samples examined and 
slide positivity rate from January to March 2019. 
Also, adjusted analysis is planned for potential ob-
served differences.
AbStrACt
Introduction Sputum smear microscopy is the 
cornerstone of tuberculosis (TB) diagnosis under the 
Revised National Tuberculosis Control Programme 
(RNTCP) in India. Instructions on how to produce a good 
sputum sample are a part of RNTCP training manuals, 
but its assessment is not emphasised. Healthcare 
provider’s instruction to expectorate a good sputum 
sample has limitations. Presumptive TB patients often 
submit inadequate (in quantity and/or quality) sputum 
samples, which may result in false- negative results. 
Objectives of the study are, among the selected RNTCP 
designated microscopy centres in Dakshina Kannada 
district, Karnataka, India, (a) to assess the effectiveness of 
mobile phone instructional video demonstrating sputum 
expectoration on sputum quality and quantity and (b) to 
explore the mobile phone video implementation challenges 
as perceived by the healthcare providers.
Methods and analysis This is a pragmatic, prospective, 
non- randomised controlled trial in two pairs of RNTCP 
Designated Microscopy Centres (located at secondary and 
primary healthcare facilities) of Dakshina Kannada district, 
India. Presumptive pulmonary TB patients aged ≥18 years 
will be included. We will exclude who are severely ill, blind, 
hearing impaired, patients who have already brought 
their sputum for examination, and transported sputum. In 
the intervention group, participants will watch a mobile 
phone instructional video demonstrating submission of an 
adequate sputum sample. The control group will follow 
the usual ongoing procedure for sputum submission. This 
study would require 406 participants for each group to 
achieve a power of 90% for detecting a difference of 15% 
between the two groups. The participant enrolment started 
in December 2019.
Ethics and dissemination Yenepoya University 
Ethics Committee, Mangaluru, India, has approved the 
study protocol (YEC-1/158/2019). It complies with the 
Declaration of Helsinki, local laws, and the International 
Council for Harmonization- good clinical practices. 
Investigators will present the results in scientific forums, 
publish in a scientific journal, and share with RNTCP 
officers.
trial registration number Clinical Trial Registry of India 
(CTRI/2019/06/019887).
IntroduCtIon
Tuberculosis (TB) is caused by Mycobacte-
rium tuberculosis and is the leading cause of 
death from a single infectious agent across 
the globe.1 To reach the 2030 WHO End TB 
Strategy milestones, the current global rate of 
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decline in TB incidence needs to be accelerated from 2% 
to 4%–5% annually.1 Early diagnosis and adequate treat-
ment is one of the key approaches to achieve this.
India is a middle- income country and accounts for 
27% of the global TB burden in 2017. By adapting 
the WHO End TB strategy, India is accelerating its TB 
control efforts and witnessing a declining trend.1 2 The 
sputum microscopy is one of the mainstays of diagnosis 
for pulmonary TB (PTB) under the Revised National 
Tuberculosis Control Programme (RNTCP).3 In RNTCP, 
two sputum samples are collected from presumptive PTB 
patients within a day or two consecutive days.3 To detect 
the acid- fast Mycobacteria in sputum, the sample should 
be expectorated from the lungs after taking a deep 
breath; good quality sputum contains more of mucus 
and less of saliva.4 The sensitivity of the sputum smear 
microscopy varies from 45% to 75%,5 6 and it could be 
further compromised if sputum samples are inadequate 
in quantity and quality. These missed patients are most 
likely to transmit the infection and may lead to delay in 
diagnosis. An adequate sputum sample is essential for 
accurate TB diagnosis. However, sputum quantity and 
quality assessment are usually not emphasised both in 
high- and low- burden settings.7 A study from 16 health 
centres in Indonesia (ranked third in global TB burden 
and adapted the WHO End TB strategy with sputum 
microscopy as the mainstay of diagnosis) reported that 
45.9% and 46% of the 1168 sputum samples were poor 
in quantity (<3 mL) and quality (saliva), respectively.8 An 
evaluation of 14 708 sputum samples in India reported 
that the sputum positivity, by both smear and culture, 
increased with improving quality (non- salivary samples) 
and increasing quantity of the sputum.9
There is profound evidence suggesting adequate 
education of presumptive PTB patients by the health-
care provider improves the sputum quantity and quality, 
and hence, TB case detection.10–12 The RNTCP training 
manual describes the steps of good sputum sample 
expectoration from the lungs.3 However, the method to 
convey the appropriate information to patients in the 
right manner is a daunting task. In addition to patient- 
related factors, healthcare service provider’s experience, 
motivating skills, attitude and compliance with sputum 
collection procedure may influence the sputum quan-
tity and quality submitted by presumptive PTB patients.8 
Health education videos have been effectively used as 
public health intervention tools and had a positive impact 
on attitudes and behavioural change in populations of 
different age groups.13–16 Mobile phone video demon-
strating sputum expectoration could be a feasible and 
sustainable option to improve the sputum sample quan-
tity and quality. Moreover, it can be incorporated in the 
existing RNTCP with minimal cost implications, if found 
effective.
objectives
Among the selected RNTCP designated microscopy 
centres (DMC) in Dakshina Kannada district, Karnataka, 
India (a) to assess the effectiveness of mobile phone 
instructional video demonstrating sputum expectoration 
on sputum quality and quantity (b) to explore the mobile 




Prospective pragmatic non- randomised controlled trial.
Study setting and groups
Dakshina Kannada is a coastal district located in the 
southern part of Karnataka state, India. According to 
census 2011 data, it has a population of about 2.1 million, 
with an average literacy rate of 88.6%.17 The public health 
infrastructure consists of 1 district hospital, 8 community 
health centres, 4 first referral units, 65 rural and 12 urban 
primary health centres.18 Under the RNTCP, all these 
public health facilities have a DMC and, TB diagnosis and 
treatment are offered free of cost. Within the framework 
of the National Health Mission, Tuberculosis Unit (TU) 
is the subdistrict level RNTCP supervisory unit covering 
a population of about 0.25 million.3 There are seven 
TUs in Dakshina Kannada district, Karnataka state, India. 
According to Dakshina Kannada district TB office report, 
from January to March 2019, a total of 7341 presumptive 
PTB patients were referred for sputum examination in 
the public health facilitates of Dakshina Kannada district. 
Of these, 311 patients were positive for TB.
For this study, investigators will use purposive sampling 
to select two DMCs located at secondary healthcare 
(SDMC) and two DMCs located at primary healthcare 
(PDMC) facilities. Purposive selection of DMCs is based 
on the similarity in the number of sputum sample exam-
inations and slide positivity rate from January to March 
2019. All the presumptive PTB patients attending one 
pair of DMCs (SDMC and PDMC) will receive the inter-
vention, and the other pair (SDMC and PDMC) will follow 
the ongoing routine procedure for sputum submission.
Study period
December 2019 to February 2020
Participants and methods
Inclusion criteria
A presumptive patient of PTB (any of the symptoms or 
signs of TB including cough >2 weeks, fever >2 weeks, 
significant weight loss >5% in last 3 months, haemoptysis 
or any abnormalities in chest radiography) aged ≥18 years 
coming to the selected DMC for sputum submission will 
be included.
Exclusion criteria
Severely ill, blind (unable to count the fingers in daylight 
at a one- metre distance), hearing impaired (who cannot 
hear the mobile phone audio with or without hearing 
aid), patients who have already brought their sputum for 
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examination and patients of transported sputum will be 
excluded.
Intervention (mobile phone instruction video)
A team of researchers from Interactive Research and 
Development (IRD, http:// ird. global/), Pakistan devel-
oped a sputum submission instructional video to improve 
the diagnostic quality of sputum samples (‘Good sputum, 
better diagnosis’, available at http:// youtu. be/ 92dT_ 
1kbbek).19 This video demonstrates the step- by- step 
procedure of submitting a good quality and quantity 
sputum sample. It is translated into Kannada by Karna-
taka Health Promotion Trust (KHPT, http://www. khpt. 
org/), Bangalore, India. The length of the video is 
approximately 4 min. To suit the objectives of this study 
and nature of the intervention, we will prepare a short 
video by adapting and further developing the Kannada 
version of ‘Good sputum, better diagnosis’. We have 
obtained the necessary permissions from IRD, Pakistan 
and KHPT, India to modify and adapt the video to the 
local context. To reach a broad consensus, we will share 
the adapted video in Kannada with the District TB officer, 
two independent subject experts, and two communi-
cation experts for further validation. We will also pilot 
the adapted video on five presumptive pulmonary TB 
patients attending a DMC, who are not part of our study. 
If necessary, we will further modify the video based on 
the feasibility and feedback (ease of understanding) from 
those five presumptive pulmonary TB patients and two 
laboratory technicians working under RNTCP.
data collection procedure
Research coordinators for the project shall be placed 
at all the four study centres. Investigators will train 
the research coordinators to explain the purpose and 
details of the study in the local language, obtain written 
informed consent, assess the quality and quantity of the 
sputum sample, and record relevant information on 
a semi- structured questionnaire. Also, two of them, in 
the intervention arm, will be trained to administer the 
intervention and obtain feedback from every fifth study 
participant.
In the intervention group, after assessing the eligibility, 
the research coordinator will explain the purpose and 
details of the study. After obtaining written informed 
consent, presumptive PTB patient will watch the instruc-
tional video on mobile, demonstrating the step- by- step 
procedure of submitting a good quality and quantity 
sputum. The instructional video will be shown again if the 
participant says that he/she did not understand the steps 
of the sputum expectoration procedure. Based on his/her 
understating, the participant will collect and submit the 
sputum in a sputum container provided under RNTCP. 
The research coordinator will collect relevant informa-
tion from the participants by using a semi- structured 
questionnaire. The research coordinator will also collect 
feedback on the video and sputum submission experience 
from every fifth study participant. The RNTCP laboratory 
technician will note the quantity (by comparing it with a 
premarked standardised empty container) and assess the 
quality (by comparing it with standard photographs) of 
the sputum sample.
In the control group, presumptive PTB patients will 
submit the sputum sample according to the usual ongoing 
procedure. By using a semi- structured questionnaire, the 
research coordinator will collect relevant information 
from the participants. The RNTCP laboratory techni-
cian will measure the quantity (by comparing it with a 
premarked standardised empty container) and assess the 
quality (by comparing it with standard photographs) of 
the sputum sample. To minimise the inter- observer vari-
ation, we will train the RNTCP laboratory technicians 
(in both the study groups) to assess the sputum sample 
quality by comparing it with standard photographs and 
test the reliability with kappa statistic before the enrolling 
the participants.
outcome measures and time points
The primary outcome is the proportional difference in 
the adequate sputum samples (based on the quantity and 
quality) between the study groups from December 2019 
to February 2020. The sputum sample would be consid-
ered as ‘adequate' if it is at least 2 mL and at least half of 
the sputum is thick/non- salivary (ie, mucoid, purulent, 
blood- stained or combination of these).3 Quality of the 
sputum will be categorised as mucoid (containing mucus, 
thicker than normal and either yellow or green colour), 
purulent (containing dead tissue, usually in large amount 
with foul smell, yellow or green colour), blood- stained 
(containing varying amounts of blood) or as salivary 
(transparent and watery specimen with bubbles).20 To 
minimise the bias in categorising the sputum quality, 
RNTCP laboratory technician will use standard photo-
graphs for each category to assess the sputum quality.
Secondary outcomes are the proportional differences 
in the positive sputum smear microscopy and positive 
Cartridge- Based Nucleic Acid Amplification Test for 
TB between the study groups from December 2019 to 
February 2020.
Besides, in the intervention group, investigators will 
assess the number of times the video played per partic-
ipant and obtain participant feedback on instructional 
video regarding ease of understanding, did it help, 
should it be continued and so on. The investigators will 
also collect feedback from the RNTCP laboratory tech-
nicians on the feasibility and challenges of mobile video 
implementation within programmatic settings.
Patient and public involvement
No patient involved
Figure 1 shows the proposed flow of the study partici-
pants in this trial.
Sample size and power
Based on the reported 39% of the submitted sputum 
samples by presumptive PTB as salivary,20 a design effect 
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Figure 1 Flow diagram for the trial participants. TB, tuberculosis; TU, tuberculosis unit; SDMC and PDMC, designated 
microscopic centres located at secondary and DMCs primary healthcare facilities.
of 2 (due to clustering of patients) and after applying 
continuity correction, this study would require a sample 
size of 406 for each group (ie, 812 total), to achieve a 
power of 90% for detecting a difference in proportions 
of 15% between the two groups at a two- sided p value of 
0.05.
Sensitivity analysis of sample size calculation for sputum 
quantity
Investigators will estimate the power of the study based on 
the actual number of study participants who complete the 
study and observed differences in the primary outcome 
between two study groups.
Masking
Owing to the nature of the intervention and its imple-
mentation to all the patients attending the study centres 
in the intervention group, it is not possible to mask the 
trial participants and study site coordinators (who admin-
ister the intervention). The data analyst will be masked 
during analysis. Lack of masking is unlikely to affect the 
study outcomes.
data collection, management and statistical analysis
A pretested semi- structured questionnaire will be used 
to collect the data. A blind review of the data will be 
performed for each trial participant. Data collected in 
a structured form will be double- entered, validated and 
analysed using EpiData (V.3.1 for entry and V.2.2.2.183 
for analysis; EpiData Association, Odense, Denmark). 
Statistical analysis will follow the intention- to- treat prin-
ciple. We will report the baseline participant- level socio-
demographic and key clinical characteristics, and test for 
equivalence between the groups using appropriate para-
metric or non- parametric tests. Considering the health 
centre (secondary and primary health facility level) as the 
primary sampling variable, analyses would be adjusted for 
the clustering effect. The primary outcome (proportional 
difference in the adequate sputum samples) measured 
will be analysed using logistic regression. The primary 
model will include a variable for the intervention group 
and will be adjusted for the cluster variable (by adding a 
random intercept for cluster variable using mixed effect 
models). The adjusted analysis will also be reported, that 
is, adjusting for cluster and the other covariates found 
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to be significant at the baseline level. Similarly, we will 
perform a cluster and covariate- adjusted analysis for the 
secondary outcomes. A two- sided p value of <0.05 would 
be considered significant.
Safety parameters
Intervention does not pose any risk to the participants. 
However, any adverse event during the trial will be listed 
and displayed in summary tables. The total number 
of adverse events, the minimum, maximum and mean 
number of adverse events per patient will be reported.
data monitoring committee
This trial does not require an independent data moni-
toring committee as it involves a health education 
intervention of very short duration with no risk to the 
participants.21 22
Study progress
Ethics approval and trial registration number were 
obtained in June 2019. The participant enrolment started 
in December 2019.
dISCuSSIon
Instructional videos have emerged as novel tools of 
health education. Owing to its large user base in India,23 
mobile phones have caught the attention of public health 
researchers as effective tools to enhance the impact of 
public health programme. Mobile phone reminders 
either by voice call or short message services have been 
explored to enhance TB treatment adherence and 
improve the outcomes in India, Thailand, Africa, Pakistan, 
Malaysia and Cambodia.24–29 Smartphone apps found to 
be effective in data management, better patient referral 
and improving treatment adherence and outcome for 
patients with TB in India and other countries.30–32 Simi-
larly, a study from Tanzania20 assessed the use of instruc-
tional video to improve TB patient detection. However, 
we did not find any such studies to improve the TB diag-
nosis conducted in India.
The Tanzania study20 used a 4- minute instruction video 
originally prepared by IRD, Pakistan.19 In a government 
hospital of Tanzania, 200 presumptive PTB patients were 
randomly assigned to either intervention (made to watch 
a sputum expectoration instruction video on a laptop 
in a designated room) or control group (standard oral 
instructions to expectorate sputum by healthcare workers 
of the TB clinic) before sputum submission.20 It did show 
a significant improvement in sputum volume, quality and 
sputum smear positivity. However, this study had many 
limitations. These findings may not be generalisable as it 
was a single- centre study with individual- level randomisa-
tion (high chances of contamination), administration of 
intervention under more controlled conditions, and on 
relatively small sample size. Also, the authors used a laptop 
to deliver the intervention, and the cost of adapting the 
video to the East African context was US$10 000.20 Hence, 
the scaling- up of this intervention is not possible in 
limited- resource settings due to cost implications. More-
over, implementation in remote areas is challenging due 
to the irregular power supply.
Owing to the lack of data on video- based interventions 
to improve sputum sample quantity and quality in India, 
and critical limitations of the previous study,20 this prag-
matic trial is designed wherein health centres will be 
allocated to intervention or control arm. Testing the inter-
vention within the RNTCP framework is a more practical 
approach to assess the effectiveness and also provides an 
opportunity to assess the feasibility of the intervention. 
We have purposefully selected PDMC and SDMC as these 
report different numbers of sputum sample examinations 
in each RNTCP quarter. Also, mobile phone instruction 
video demonstrating sputum submission step- by- step is a 
feasible and sustainable intervention with minimal cost 
implications if found effective. This study will also gain 
participants’ perspectives on the intervention through 
feedback.
Owing to limited resources, we adapted a non- 
randomised design for this study, which is a limitation. 
However, to limit the selection bias, we will select DMCs 
which have a similar number of sputum sample exam-
inations and slide positivity rate in an RNTCP quarter 
(January to March 2019). Besides, adjusted analysis is 
planned for potential observed differences.
Ethics and dissemination
After obtaining the written informed consent, investi-
gators will replace the protected personally identifiable 
information (PPII) by a research identification code. 
Face sheets containing PPIIs will be removed from the 
completed questionnaire. Only one investigator (AH) 
will have access to master code list. Locked cabinets and 
password- protected computers and files will be used to 
securely store the research data and relevant electronic 
data, respectively. The intervention in this trial (mobile 
phone instructional video on sputum expectoration) 
neither poses any additional risk to the participants nor 
alters the diagnostic and treatment algorithm for pulmo-
nary TB patients under RNTCP. Hence, trial participants 
will not be eligible for any compensation. Following anal-
ysis of the data, investigators will present the results in 
scientific forums and publish them in a scientific journal. 
Further, the investigators will share the results with both 
district and state- level RNTCP officers.
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